# Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)

> **NCT06569342** · — · COMPLETED · sponsor: **University of Aarhus** · enrollment: 43 (actual)

## Conditions studied

- Overactive Bladder
- Incontinence, Daytime Urinary
- Incontinence, Nighttime Urinary

## Interventions

- **PROCEDURE:** Intradetrusor BoNT-A

## Key facts

- **NCT ID:** NCT06569342
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-15
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569342, "Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06569342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*